Around 5,000 UK women are taking the HRT pill Prempro which was at the centre of a media health scare last week.
The women are volunteers in a UK trial of the drug which is almost identical to the US study stopped last week, three years early.
The US trial of 16,600 postmenopausal women found that Prempro, a combined oestrogen and progestogen pill, significantly increased the risk of breast cancer, CHD and stroke after five years' use. The risks were found to outweigh benefits of preventing osteoporotic fractures and reducing the risk of colorectal cancer.
The Medical Research Council is meeting this week to discuss whether its UK WISDOM trial …